Form 8-K - Current report:
SEC Accession No. 0000950170-25-075783
Filing Date
2025-05-21
Accepted
2025-05-21 16:15:15
Documents
11
Period of Report
2025-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-20250521.htm   iXBRL 8-K 90312
2 EX-10.1 alks-ex10_1.htm EX-10.1 135698
  Complete submission text file 0000950170-25-075783.txt   368073

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20250521.xsd EX-101.SCH 30630
14 EXTRACTED XBRL INSTANCE DOCUMENT alks-20250521_htm.xml XML 4683
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 25973322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)